Measure of Engagement of Epilepsy Patients in Messaging Groups

Epilepsy Clinical Trial

Official title:

Measure of Engagement of Epilepsy Patients in Messaging Groups and Group Characteristics That Influence Engagement.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03076645
• Other study ID #: 203594
• Status: Completed
• Phase: N/A
• First received: February 2, 2017
• Last updated: October 11, 2017
• Start date: October 1, 2016
• Est. completion date: August 10, 2017

Study information

• Verified date: October 2017
• Source: Royal Free Hospital NHS Foundation Trust
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will measure the engagement of people with epilepsy in a mobile phone based messaging platform as well as understand if there is an impact on their self-management

Description:

The primary purpose of this study is to assess a person with epilepsy's level of usage of a mobile messaging application for peer support. The secondary purpose is to understand what characteristics of their group drive different levels of usage and improvements in self-management.

Participants can participate as much or little as they want for a minimum of six weeks. Participants will complete an initial and a final questionnaire.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 202
• Est. completion date: August 10, 2017
• Est. primary completion date: August 10, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Age, diagnosis of epilepsy, have access to a smartphone capable of running messaging application

Exclusion Criteria:

• A diagnosis of learning disability/difficulty, significant mental health conditions; those in care, bereaved, or prisoners. Any other vulnerable individuals (individuals unable to protect themselves against significant harm or exploitation)

Related Conditions & MeSH terms

• Epilepsy

Intervention

Behavioral:
• Facilitator support and education
Group engaged with facilitator support and education

Locations

Country	Name	City	State
United Kingdom	Lewisham & Greenwich NHS Trust	Lewisham
United Kingdom	Barts and The London NHS Trust	London
United Kingdom	National Hospital for Neurology and Neurosurgery	London
United Kingdom	Royal Free Hospital	London
United Kingdom	Kent Community Health NHS Trust	Maidstone

Sponsors (1)

Lead Sponsor	Collaborator
Royal Free Hospital NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Engagement	Average participant number of posts over time frame assessed by tracking number of participant entries	6 weeks
Secondary	Epilepsy self-management	Patient activation measure based on self-reported questionnaire	Change in Baseline to 6 weeks
Secondary	Epilepsy medication adherence	Medication adherence based on self-reported questionnaire	Change in Baseline to 6 weeks
Secondary	Epilepsy quality of life	Quality of life in epilepsy metric based on self-reported questionnaire	Change in Baseline to 6 weeks